Anna Jones, PhD

St. Jude is at the forefront of creating tools to visualize and analyze genomic data.

St. Jude scientists are fueling progress by studying the molecular groups of different cancers.

The St. Jude HPV Cancer Prevention Program and the University of Memphis created Tigers VAX Now, a student ambassador program to empower college students to advocate for HPV vaccination as cancer prevention among their peers.

Scientists at St. Jude are leading the way on understanding cancer predisposition and the way that inherited genetics can inform patient care.

Scientists at St. Jude Children’s Research Hospital are deploying genomic technologies to hunt for vulnerabilities in cancer.

Participants in the St. Jude HPV Cancer Prevention Program’s HPV Cancer Survivors School are using their powerful voices to advocate for HPV vaccination during January which is Cervical Cancer Awareness Month.

St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.

Sometimes a scientist’s next step isn’t a step, but more of a career-defining leap. Early-career investigator Lily Guenther, MD, shares her experience of taking that leap and starting a laboratory at St. Jude.

St. Jude computational biologists created a computational score predicting cancer drug sensitivity to HDAC6 inhibitors in a promising phase Ib clinical trial.

St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.